INS and type 1 diabetes mellitus: Dysregulated glucose-induced insulin secretion is a well-established feature of T2D (83–87) and also reported in T1D patients prior to disease onset (88–92), suggesting a possible link between insulin secretory defects and activation of inappropriate autoimmune responses.